The company’s disclosure emphasizes multiple dimensions of organizational resilience, beginning with its recognition in Item 1A of “a number of risks that if realized could materially adversely affect its business, results of operations, cash flow, financial condition or prospects,” a clear acknowledgment of the need for positive adjustment under challenging conditions.  It describes the impact of the global COVID-19 pandemic on business continuity—“the company is unable to predict the full extent to which the COVID-19 pandemic or any future pandemic, epidemic or similar public health threat will adversely impact its business, operations, financial performance, results of operations, and financial condition”—and outlines the resilience strategies enacted, including employee safety measures, ensuring supply of medicines and vaccines, continuation of clinical studies, accelerated antiviral and vaccine research programs, and contributions of scientific expertise.  The company further illustrates operational flexibility through its global restructuring program, “a worldwide initiative focused on further optimizing the company’s manufacturing and supply network, as well as reducing its global real estate footprint,” which is expected to yield $900 million in annual savings by 2023, and through risk‐mitigation measures such as foreign currency revenue hedging, balance sheet risk management using forward contracts, and interest rate swap contracts to stabilize cash flows and protect system integrity.  Cyber‐resilience is highlighted by the response to the 2017 network cyber-attack—“the company experienced a network cyber-attack that led to a disruption of its worldwide operations,” followed by an enterprise-wide effort “to enhance the company’s resiliency against future cyber-attacks,” to “improve the speed of the company’s recovery from such attacks and enable continued business operations to the greatest extent possible.”  In the face of supply-chain fragmentation risks from natural disasters and pandemics, the company reports contingency planning for manufacturing shutdowns, distribution delays and “further pricing pressures, government-mandated pricing actions and cost-containment measures worldwide,” together with the maintenance of a $6 billion backup credit facility and diversified capital allocation to acquisitions, collaborations and continuous R&D investments.  Its detailed risk factors also include “disruptive events” such as war, terrorism, riot, civil insurrection, famine, flood, fire, earthquake, storm or disease, reflecting an explicit systemic perspective on environmental perturbations, and the company’s proactive use of “accounts receivable factoring” and contingent milestone structures to preserve cash flow and resource generation.  Through alliances, acquisitions and spin-offs—such as the planned organon distribution to streamline focus—and dynamic capabilities in R&D, manufacturing, regulatory engagement and financial hedging, the company underscores its ability to absorb strain, preserve functioning, adapt to unexpected situations, and position itself for performance maintenance under both nominal and exceptional conditions.